Literature DB >> 7968294

Proton spectroscopy in HIV infection: relaxation times of cerebral metabolites.

I D Wilkinson1, M Paley, W K Chong, B J Sweeney, J K Shepherd, B E Kendall, M A Hall-Craggs, M J Harrison.   

Abstract

In vivo proton spectroscopy has demonstrated abnormalities in the cerebral metabolite ratios from subjects with acquired immunodeficiency syndrome (AIDS). Some of the sequences employed are subject to T1 or T2 weighting, which may affect spectroscopic interpretation. The relaxation times of choline (Cho), creatine (Cr), and N-acetyl (NA) resonances have been estimated at 1.5 T in 21 patients infected with the human immunodeficiency virus (HIV) and 8 controls using gradient localised, spin-echo spectroscopic sequences of varying echo and repetition times. A statistically significant increase in the T2 of NA was found in the HIV seropositive patients who had diffuse abnormalities on MR imaging consistent with HIV encephalopathy (493 +/- 199 ms) when compared to controls (292 +/- 118 ms; p < .05). No other statistically significant differences were found in the relaxation times between patients and control subjects. These results demonstrate that signals from the NA resonance obtained using long echo time sequences in subjects who are HIV seropositive are not solely indicative of metabolite concentration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7968294     DOI: 10.1016/0730-725x(94)92036-2

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  7 in total

1.  Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS.

Authors:  I D Wilkinson; S Lunn; K A Miszkiel; R F Miller; M N Paley; I Williams; R J Chinn; M A Hall-Craggs; S P Newman; B E Kendall; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

2.  Magnetic resonance spectroscopy of the normal cerebellum: what degree of variability can be expected?

Authors:  Stuart Currie; Marios Hadjivassiliou; Iain David Wilkinson; Paul David Griffiths; Nigel Hoggard
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

3.  Proton spectroscopy and imaging at 3T in ataxia-telangiectasia.

Authors:  L I Wallis; P D Griffiths; S J Ritchie; C A J Romanowski; G Darwent; I D Wilkinson
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

4.  Metabolite concentrations and relaxation in perinatal cerebral hypoxic-ischemic injury.

Authors:  E B Cady
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

5.  Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex.

Authors:  W Mukonoweshuro; I D Wilkinson; P D Griffiths
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

6.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis.

Authors:  Ivan I Kirov; Assaf Tal
Journal:  Magn Reson Med       Date:  2019-08-08       Impact factor: 4.668

Review 7.  Magnetic resonance imaging of the central nervous system in diabetic neuropathy.

Authors:  Iain D Wilkinson; Dinesh Selvarajah; Marni Greig; Pallai Shillo; Elaine Boland; Rajiv Gandhi; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.